Writer, I think you have answered Qantum's very good question from the other day.
Sales will be brought to account during 2011 and 2012 as a result of up front licence fees from a handful from the dozen pharmas currently in discussion with UNI. Also, advance orders for the Unifill to build up inventories whilst aging in complete. Whilst SA will not want too much working capital tied up with stock sitting on the shelf, they are only 1 out of many potential UNI customers, and only a small percentage of output has been guaranteed to SA as part of the industrialisation agreement.
The size and timing of the about is uncertain, certainly will be an interesting year. IMO a re-rating by the aussie market is due and will be boosted with a take up by the Yanks.
- Forums
- ASX - By Stock
- UNS
- production commence end of q1
production commence end of q1, page-10
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add UNS (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, MD & CEO
Anthony Noble
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online